Revenue Breakdown
Composition ()
No data
Revenue Streams
BioCardia Inc (BCDA) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Reconstructive Division, accounting for 92.7% of total sales, equivalent to $521.00K. Another important revenue stream is Spine Division. Understanding this composition is critical for investors evaluating how BCDA navigates market cycles within the Biotechnology & Medical Research industry.
Profitability & Margins
Comparative Benchmarking
In the context of the broader market, BCDA competes directly with industry leaders such as RGNT and BIVI. With a market capitalization of $10.58M, it holds a significant position in the sector. When comparing efficiency, BCDA's gross margin of N/A stands against RGNT's N/A and BIVI's N/A. Such benchmarking helps identify whether BioCardia Inc is trading at a premium or discount relative to its financial performance.
